Energy Production and Metabolism Practice Questions

Q: Which enzyme in the citric acid cycle is directly inhibited by high levels of ATP?

Isocitrate dehydrogenase. ***Isocitrate dehydrogenase*** - **Isocitrate dehydrogenase** is a key regulatory enzyme in the **citric acid cycle** that is allosterically inhibited by high levels of **ATP** and **NADH**. - This inhibition signals abundant cellular energy, slowing down the cycle to prevent overproduction of ATP when energy demands are low. *Aconitase* - **Aconitase** catalyzes the **reversible isomerization of citrate to isocitrate**; it is not directly regulated by ATP levels. - Its activity is sensitive to **iron-sulfur cluster** integrity and can be inhibited by fluoroacetate derivatives. *Malate dehydrogenase* - **Malate dehydrogenase** catalyzes the **reversible oxidation of malate to oxaloacetate**, generating NADH. - Its activity is primarily regulated by the **NADH/NAD+ ratio**, not directly by ATP levels. *Succinate dehydrogenase* - **Succinate dehydrogenase** (Complex II of the electron transport chain) oxidizes **succinate to fumarate** and is part of both the citric acid cycle and oxidative phosphorylation. - It is primarily inhibited by **oxaloacetate** and **malonate**, and is not a major regulatory point for ATP feedback inhibition in the citric acid cycle.

Q: Which of the following is NOT true regarding the role of NAD+?

Functions as an antioxidant. ***Functions as an antioxidant*** - **NAD+** primarily functions as an **electron carrier** in redox reactions, not as an antioxidant that directly neutralizes reactive oxygen species. - While it plays a role in maintaining cellular redox balance, its direct function is not scavenging free radicals like **glutathione** or **vitamins C and E**. *Acts as an electron carrier* - **NAD+** is a crucial coenzyme that accepts electrons and protons during metabolic reactions, converting into **NADH**. - **NADH** then donates these electrons to the **electron transport chain** to generate **ATP**. *Participates in glycolysis* - In glycolysis, **NAD+** is reduced to **NADH** during the oxidation of **glyceraldehyde-3-phosphate** to **1,3-bisphosphoglycerate**. - This step is vital for producing **ATP** and regenerating **NAD+** for continued glycolytic flux. *Involved in TCA cycle* - **NAD+** is reduced to **NADH** at several steps in the **TCA cycle**, including the conversion of **isocitrate to α-ketoglutarate**, **α-ketoglutarate to succinyl CoA**, and **malate to oxaloacetate**. - These **NADH** molecules are then funneled into the **electron transport chain** for oxidative phosphorylation.

Q: What are the products of the isocitrate to α-ketoglutarate conversion in the TCA cycle?

NADH, CO2. ***NADH, CO2*** - The conversion of **isocitrate to α-ketoglutarate** is an oxidative decarboxylation step catalyzed by **isocitrate dehydrogenase**. - This reaction produces **NADH** (from NAD+) and **carbon dioxide (CO2)**, as a carbon atom is lost. *GTP, CO2* - **GTP** is produced during the conversion of **succinyl-CoA to succinate** in a substrate-level phosphorylation step, not during the isocitrate to α-ketoglutarate conversion. - While CO2 is produced in the latter, GTP is not. *NADPH, H2O* - **NADPH** is primarily generated in the **pentose phosphate pathway** and is used for reductive biosynthesis, not directly produced in the TCA cycle. - **H2O** is consumed or produced in other steps of the TCA cycle but not as a direct product of this specific reaction. *FADH2, ATP* - **FADH2** is produced during the conversion of **succinate to fumarate** by succinate dehydrogenase. - **ATP** (or GTP which can be converted to ATP) is produced in the succinyl-CoA to succinate step, not at the isocitrate dehydrogenase step.

Q: How does cyanide inhibit the electron transport chain?

Inhibits complex IV. ***Inhibits complex IV*** - Cyanide binds with high affinity to the **ferric (Fe3+) iron** in the heme a3 component of **cytochrome c oxidase** (Complex IV). - This binding completely blocks the transfer of electrons to **oxygen**, halting the entire electron transport chain and oxidative phosphorylation. *Inhibits complex III (cytochrome bc1 complex)* - While inhibitors exist for Complex III (e.g., **antimycin A**), cyanide specifically targets Complex IV, not Complex III. - Complex III is involved in transferring electrons from ubiquinol to cytochrome c. *Directly inhibits ATP synthase* - Cyanide does not directly inhibit **ATP synthase**; its primary action is upstream in the electron transport chain. - ATP synthase is responsible for using the proton gradient to produce ATP, and its inhibition would be by agents like **oligomycin**. *Inhibits complex I (NADH dehydrogenase)* - Complex I is inhibited by compounds like **rotenone** or **amytal**, which block the transfer of electrons from NADH to ubiquinone. - Cyanide's mechanism of action is distinct and occurs later in the chain.

Q: How many molecules of NADH are produced by the TCA cycle per acetyl-CoA molecule?

3. **3** - Each turn of the **tricarboxylic acid (TCA) cycle** (Krebs cycle) directly produces **three molecules of NADH** from one molecule of acetyl-CoA. - These NADH molecules are crucial for subsequent **oxidative phosphorylation**, where they contribute to the production of ATP. *1* - Only one molecule of **FADH2** is produced per acetyl-CoA in the TCA cycle, not NADH. - The single **GTP/ATP** molecule is also produced directly within the cycle. *2* - While other stages of glucose metabolism, such as glycolysis, produce two NADH molecules, the **TCA cycle itself yields three NADH** per acetyl-CoA. - Two pyruvate molecules from one glucose molecule enter the TCA cycle (after conversion to acetyl-CoA), so considering one glucose, the cycle produces six NADH in total. *4* - The full oxidative phosphorylation pathway, including the electron transport chain, processes the NADH in stages, but the **direct production within the TCA cycle** is limited to three. - Four molecules of NADH are not directly produced in any single phase of the TCA cycle from one acetyl-CoA input.

Q: What is the PRIMARY metabolic consequence of a mutation in the gene encoding NADH dehydrogenase (Complex I) that directly impacts cellular energy production?

Decreased ATP synthesis. ***Decreased ATP synthesis*** - A mutation in **NADH dehydrogenase (Complex I)** reduces its ability to pump protons across the inner mitochondrial membrane, directly impairing the **proton gradient** essential for **ATP synthase** function. - This leads to a significant reduction in the efficiency of **oxidative phosphorylation** and, consequently, **decreased ATP production**, which is the primary metabolic defect in mitochondrial disorders. - This represents the most direct impact on cellular energy metabolism. *Normal electron transport efficiency* - Mutations in **Complex I** directly impair its function, leading to **decreased electron flow** through the electron transport chain. - Therefore, **normal electron transport efficiency** cannot occur with a dysfunctional NADH dehydrogenase. *Impaired oxidative phosphorylation* - While this is true, it describes the mechanism rather than the ultimate metabolic consequence. - Impaired OXPHOS is the process defect, whereas **decreased ATP synthesis** is the direct metabolic outcome affecting cellular function. *Increased production of reactive oxygen species* - Complex I dysfunction does lead to increased **ROS production** due to electron leakage, which contributes to oxidative damage in mitochondrial disorders. - However, when considering the **primary metabolic consequence** affecting energy production, the direct outcome is **insufficient ATP synthesis**, which causes the cellular energy deficiency characteristic of these disorders.

Q: A newborn presents with severe metabolic acidosis and high levels of lactate. Genetic testing reveals a mutation in the PDH complex. Which condition is most likely?

Pyruvate dehydrogenase deficiency. ***Pyruvate dehydrogenase deficiency*** - A mutation in the **pyruvate dehydrogenase (PDH) complex** directly impairs the conversion of pyruvate to acetyl-CoA, leading to a build-up of **pyruvate**. - Excess pyruvate is then shunted to lactate via **lactate dehydrogenase**, resulting in severe **lactic acidosis**. *Phenylketonuria* - This condition involves a deficiency in **phenylalanine hydroxylase**, leading to an accumulation of phenylalanine, not pyruvate or lactate. - Clinical features include developmental delay, seizures, and a musty odor, distinct from severe metabolic acidosis in a newborn. *Glycogen storage disease* - These disorders involve defects in **glycogen metabolism** and present with hypoglycemia, hepatomegaly, or muscle weakness depending on the specific type. - While some types can cause lactic acidosis, the primary defect is not in the PDH complex, and the clinical picture often involves **hypoglycemia** or **organ enlargement**. *Ornithine transcarbamylase deficiency* - This is an **X-linked urea cycle disorder** characterized by hyperammonemia, leading to neurological symptoms like lethargy, seizures, and coma. - It does not primarily present with severe lactic acidosis due to a defect in the PDH complex.

Q: What is the biochemical mechanism by which cyanide inhibits cellular respiration?

Inhibition of Complex IV in the electron transport chain. ***Inhibition of Complex IV in the electron transport chain*** - **Cyanide** acts as a potent poison by binding irreversibly to the **ferric iron (Fe3+)** in the heme a3 component of **cytochrome c oxidase (Complex IV)**. - This binding prevents the transfer of electrons to oxygen, thereby arresting the entire **electron transport chain** and halting ATP production. *Uncoupling of oxidative phosphorylation* - **Uncoupling agents** (e.g., dinitrophenol) dissipate the proton gradient across the inner mitochondrial membrane, allowing electron transport to continue without ATP synthesis. - While this also reduces ATP, it is a different mechanism from cyanide's direct inhibition of electron flow. *Blockage of ATP synthase* - **ATP synthase (Complex V)** is responsible for synthesizing ATP using the proton gradient generated by the electron transport chain. - Inhibitors like **oligomycin** block this enzyme, preventing ATP production but not directly stopping electron transport. *Reduction of NADH production* - **NADH production** occurs during glycolysis and the citric acid cycle, upstream of the electron transport chain. - Cyanide does not directly interfere with these metabolic pathways; its primary action is at the terminal oxidation step.

Q: A patient exhibits symptoms of lactic acidosis and hyperlipidemia. Genetic testing reveals a mutation in the enzyme pyruvate dehydrogenase complex. Which metabolic process is directly affected?

Citric acid cycle. ***Citric acid cycle*** - The **pyruvate dehydrogenase complex (PDC)** catalyzes the irreversible conversion of **pyruvate to acetyl-CoA**, which is the essential substrate that enters the citric acid cycle. - This reaction is the **critical link between glycolysis and the citric acid cycle**, and its impairment directly reduces the availability of acetyl-CoA for oxidative metabolism. - A mutation in PDC leads to pyruvate accumulation, which is then converted to **lactate** (causing **lactic acidosis**), and reduces acetyl-CoA production for the citric acid cycle, impairing **energy generation** and promoting **hyperlipidemia** due to impaired fatty acid synthesis regulation. *Glycolysis* - Glycolysis converts **glucose into pyruvate** and remains functionally intact in PDC deficiency. - A defect in PDC causes pyruvate to *accumulate* rather than being converted to acetyl-CoA, but does not directly impair the glycolytic pathway itself. - The lactic acidosis occurs *downstream* of glycolysis due to pyruvate buildup. *Gluconeogenesis* - Gluconeogenesis synthesizes glucose from non-carbohydrate precursors (lactate, amino acids, glycerol) primarily in liver and kidney. - While PDC deficiency affects carbohydrate metabolism broadly, gluconeogenesis itself is not the primary process directly impacted by loss of pyruvate-to-acetyl-CoA conversion. - PDC deficiency typically does not present with hypoglycemia as the primary feature. *Fatty acid oxidation* - Fatty acid oxidation (β-oxidation) breaks down fatty acids to produce acetyl-CoA independently of PDC. - PDC deficiency affects acetyl-CoA production *from carbohydrate sources*, not from fatty acid breakdown. - The hyperlipidemia results from impaired lipid metabolism and energy dysregulation, not from defective fatty acid oxidation itself.

Question 1

Which enzyme in the citric acid cycle is directly inhibited by high levels of ATP?

Accepted Answer

Isocitrate dehydrogenase

Answer

Aconitase

Answer

Malate dehydrogenase

Answer

Succinate dehydrogenase

Question 2

Which of the following is NOT true regarding the role of NAD+?

Accepted Answer

Functions as an antioxidant

Answer

Acts as an electron carrier

Answer

Participates in glycolysis

Answer

Involved in TCA cycle

Question 3

What are the products of the isocitrate to α-ketoglutarate conversion in the TCA cycle?

Accepted Answer

NADH, CO2

Answer

GTP, CO2

Answer

NADPH, H2O

Answer

FADH2, ATP

Question 4

How does cyanide inhibit the electron transport chain?

Accepted Answer

Inhibits complex IV

Answer

Inhibits complex III (cytochrome bc1 complex)

Answer

Directly inhibits ATP synthase

Answer

Inhibits complex I (NADH dehydrogenase)

Question 5

How many molecules of NADH are produced by the TCA cycle per acetyl-CoA molecule?

Accepted Answer

3

Answer

1

Answer

2

Answer

4

Question 6

What is the PRIMARY metabolic consequence of a mutation in the gene encoding NADH dehydrogenase (Complex I) that directly impacts cellular energy production?

Accepted Answer

Decreased ATP synthesis

Answer

Normal electron transport efficiency

Answer

Increased production of reactive oxygen species

Answer

Impaired oxidative phosphorylation

Question 7

In the TCA cycle, what is the significance of the production of NADH and FADH2, and how are these molecules utilized?

Accepted Answer

They donate electrons to the electron transport chain for ATP production

Answer

They directly phosphorylate ADP to form ATP

Answer

They act as substrates for gluconeogenesis

Answer

They are used in the synthesis of fatty acids

Question 8

A newborn presents with severe metabolic acidosis and high levels of lactate. Genetic testing reveals a mutation in the PDH complex. Which condition is most likely?

Accepted Answer

Pyruvate dehydrogenase deficiency

Answer

Phenylketonuria

Answer

Glycogen storage disease

Answer

Ornithine transcarbamylase deficiency

Question 9

What is the biochemical mechanism by which cyanide inhibits cellular respiration?

Accepted Answer

Inhibition of Complex IV in the electron transport chain

Answer

Uncoupling of oxidative phosphorylation

Answer

Blockage of ATP synthase

Answer

Reduction of NADH production

Question 10

A patient exhibits symptoms of lactic acidosis and hyperlipidemia. Genetic testing reveals a mutation in the enzyme pyruvate dehydrogenase complex. Which metabolic process is directly affected?

Accepted Answer

Citric acid cycle

Answer

Glycolysis

Answer

Gluconeogenesis

Answer

Fatty acid oxidation

Energy Production and Metabolism — MCQs

Energy Production and Metabolism — MCQs

On this page

Practice by Chapter

Want unlimited practice?